Frovatriptan Succinate Tablet — FDA Drug Shortage

To Be Discontinued — Endo Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Frovatriptan Succinate Tablet (tablet) from Endo Pharmaceuticals, Inc. with status To Be Discontinued. The shortage was first posted on Feb 24, 2026.

Shortage details

Status
To Be Discontinued
Company
Endo Pharmaceuticals, Inc.
Package NDC
63481-025-09
Dosage Form
Tablet
Presentation
Frova, Tablet, 2.5 mg (NDC 63481-025-09)
Initial Posting
Feb 24, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.